<DOC>
	<DOCNO>NCT00846118</DOCNO>
	<brief_summary>The purpose study verify whether pitavastatin prevents cardiovascular event improve mortality chronic hemodialysis patient hypercholesteremia .</brief_summary>
	<brief_title>Differential Intervention Trial Standard Therapy Versus Pitavastatin Patients With Chronic Hemodialysis ( DIALYSIS )</brief_title>
	<detailed_description>It already prove clinical trial statins prevent death cardiovascular event . However , efficacy statin patient chronic hemodialysis prove yet .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>patient hemodialysis patient hypercholesterolemia define follow parameter : LDLC ≧ 100 mg / dL TC ≧ 180 mg / dL patient require cholesterollowering treatment investigator . patient aged 2075 year patient write consent volition provide sufficient explanation participation clinical trial patient take statin fibrates patient enrolled trial use contraindication drug pitavastatin patient acute myocardial infarction within six month day agreement acquisition patient schedule PCI CABG within six month day agreement acquisition Patients diagnosis doubt malignant tumor patient correspond `` Contraindications '' pitavastatin Familial hypercholesterolemia patient patient judge ineligible investigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Pitavastatin</keyword>
	<keyword>Hemodialysis</keyword>
	<keyword>Mortality</keyword>
	<keyword>Cardiovascular disease</keyword>
</DOC>